News | Radiology Business | May 05, 2020

Selected Parts of Agfa HealthCare's European IT Business Sold to the Dedalus Group

The sale to the Dedalus Group includes the electronic health record and integrated care activities in DACH, France and Brazil and specific Imaging IT activities in those regions

Sale of selected parts of the IT business to the Dedalus Group includes the electronic health record and integrated care activities in DACH, France and Brazil and specific Imaging IT activities in those regions

May 5, 2020 — Agfa HealthCare announces the successful sale of part of its IT business to the Dedalus Group at an enterprise value of 975 million euro. The part that has been sold consists of the healthcare information solutions (electronic health record, the ORBIS platform) and the integrated care activities in Germany, Austria, Switzerland, France and Brazil as well as specific Imaging IT activities in these geographies. 

The completion of the deal enables Agfa HealthCare to focus 100% on its core global Imaging IT software business, flagship solutions and customers. Agfa Imaging IT continues to be a key part and division of the Agfa-Gevaert Group, headquartered in Mortsel, Belgium and traded on Euronext Brussels (AGFB). “The sale of this business is a major step in our transformation process. The proceeds of the sale will help us to secure the future of our Group and to further implement the strategies we have developed for our various activities. Going forward, Agfa HealthCare will focus on its core Imaging IT software business. Based on our flagship Enterprise Imaging platform and the IMPAX® solutions, we will continue to deliver superior value to our Imaging IT customers,” said Pascal Juéry, president and CEO of the Agfa-Gevaert Group.

This transaction represents an exciting new phase in the evolution of Agfa HealthCare. “Agfa HealthCare has established itself as a leader in Enterprise Imaging, with the most advanced platform in the market. We are fully confident in our Enterprise Imaging platform strategy. The sale will allow us to focus our expertise and resources 100% on the value-improvement of our Enterprise Imaging offering, and on developing our role as the partner of choice for customers in all our markets,” said Luc Thijs, president of Agfa HealthCare.

Offering a proven combination of technical innovation, clinical depth and strategic guidance, Agfa HealthCare will continue to support customers’ clinical, operational and business strategies, enabling the creation of a health IT ecosystem for efficient care delivery. By helping healthcare providers manage resource allocation and productivity, our solutions play a key role in accelerating precision health and clinical confidence with patient-centric contextual intelligence.

At the center of Agfa HealthCare’s Imaging IT activities is the Enterprise Imaging platform. “Agfa HealthCare will continuously deepen its robust, scalable, and unified technology to empower clients with multispecialty, location-agnostic imaging data management solutions”, said Arto Ryymin, chief operations officer of Agfa HealthCare. Enterprise Imaging continues to expand to meet healthcare’s goals and challenges. The powerful rules-based workflow engine helps optimize tasks and improve productivity, with rapidly deployed remote reading, secure communication and real-time collaboration, and standards-based integration of best of breed AI.

For more information: www.agfahealthcare.com

Related Content

AIR Recon DL delivers shorter scans and better image quality (Photo: Business Wire)

AIR Recon DL delivers shorter scans and better image quality (Photo: Business Wire).

News | Artificial Intelligence | May 29, 2020
May 29, 2020 — GE Healthcare announced U.S.
The paradox is that COVID-19 has manifested the critical need for exactly what the rules require: advancement of interoperability and digital online access to clinical data and imaging, at scale, for care coordination and infection control.

The paradox is that COVID-19 has manifested the critical need for exactly what the rules require: advancement of interoperability and digital online access to clinical data and imaging, at scale, for care coordination and infection control. Getty Images

Feature | Coronavirus (COVID-19) | May 28, 2020 | By Matthew A. Michela
One year after being proposed, federal rules to advance interoperability in healthcare and create easier access for p
The opportunity to converge the silos of data into a cross-functional analysis can provide immense value during the COVID-19 outbreak and in the future

Getty Images

Feature | Coronavirus (COVID-19) | May 28, 2020 | By Jeff Vachon
In the midst of the coronavirus pandemic normal
In April, the U.S. Food and Drug Administration (FDA) cleared Intelerad’s InteleConnect EV solution for diagnostic image review on a range of mobile devices.
Feature | PACS | May 27, 2020 | By Melinda Taschetta-Millane
Fast, easily accessible patient images are crucial in this day and age, as imaging and medical records take on a new
Off-site imaging companies are playing a key role in the fight against COVID-19
Feature | Coronavirus (COVID-19) | May 26, 2020 | By Sean Zahniser
After the worst of the COVID-19 pandemic has pas
 Recently the versatility of mixed and augmented reality products has come to the forefront of the news, with an Imperial led project at the Imperial College Healthcare NHS Trust. Doctors have been wearing the Microsoft Hololens headsets whilst working on the front lines of the COVID pandemic, to aid them in their care for their patients. IDTechEx have previously researched this market area in its report “Augmented, Mixed and Virtual Reality 2020-2030: Forecasts, Markets and Technologies”, which predicts th

Doctors wearing the Hololens Device. Source: Imperial.ac.uk

News | Artificial Intelligence | May 22, 2020
May 22, 2020 — Recently the versatility of